Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Acute myeloid leukemia 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
2 Amoebiasis 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
3 Coronavirus disease - COVID-19 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
4 Cytokine-cytokine receptor interaction 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
5 Cytokine-cytokine receptor interaction 💬
 [1] CSF2RA 💬 Mavrilimumab 💬 Mavrilimumab [2] 41, 46 💬
6 Cytokine-cytokine receptor interaction 💬
 [1] CSF2RA 💬 Molgramostim 💬 Molgramostim [2] 229, 299 💬
7 Cytokine-cytokine receptor interaction 💬
 [1] CSF2RA 💬 Regramostim 💬 Regramostim [1] 229 💬
8 Cytokine-cytokine receptor interaction 💬
 [1] CSF2RA 💬 Sargramostim 💬 Sargramostim [7]  6 , 28, 60, 62, 96, 229, 285 💬
9 Fc epsilon RI signaling pathway 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
10 Hematopoietic cell lineage 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
11 Hematopoietic cell lineage 💬
 [1] CSF2RA 💬 Mavrilimumab 💬 Mavrilimumab [2] 41, 46 💬
12 Hematopoietic cell lineage 💬
 [1] CSF2RA 💬 Molgramostim 💬 Molgramostim [2] 229, 299 💬
13 Hematopoietic cell lineage 💬
 [1] CSF2RA 💬 Regramostim 💬 Regramostim [1] 229 💬
14 Hematopoietic cell lineage 💬
 [1] CSF2RA 💬 Sargramostim 💬 Sargramostim [7]  6 , 28, 60, 62, 96, 229, 285 💬
15 Human T-cell leukemia virus 1 infection 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
16 IL-17 signaling pathway 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
17 JAK-STAT signaling pathway 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
18 JAK-STAT signaling pathway 💬
 [1] CSF2RA 💬 Mavrilimumab 💬 Mavrilimumab [2] 41, 46 💬
19 JAK-STAT signaling pathway 💬
 [1] CSF2RA 💬 Molgramostim 💬 Molgramostim [2] 229, 299 💬
20 JAK-STAT signaling pathway 💬
 [1] CSF2RA 💬 Regramostim 💬 Regramostim [1] 229 💬
21 JAK-STAT signaling pathway 💬
 [1] CSF2RA 💬 Sargramostim 💬 Sargramostim [7]  6 , 28, 60, 62, 96, 229, 285 💬
22 Kaposi sarcoma-associated herpesvirus infection 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
23 Natural killer cell mediated cytotoxicity 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
24 Pathways in cancer 💬
 [1] CSF2RA 💬 Mavrilimumab 💬 Mavrilimumab [2] 41, 46 💬
25 Pathways in cancer 💬
 [1] CSF2RA 💬 Molgramostim 💬 Molgramostim [2] 229, 299 💬
26 Pathways in cancer 💬
 [1] CSF2RA 💬 Regramostim 💬 Regramostim [1] 229 💬
27 Pathways in cancer 💬
 [1] CSF2RA 💬 Sargramostim 💬 Sargramostim [7]  6 , 28, 60, 62, 96, 229, 285 💬
28 Rheumatoid arthritis 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
29 Shigellosis 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
30 T cell receptor signaling pathway 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
31 TNF signaling pathway 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬
32 Transcriptional misregulation in cancer 💬
 [1] CSF2 💬 Otilimab 💬 Otilimab [1] 46 💬

Back to top